文献速递自身免疫性与大疱性皮肤病

IgA天疱疮中FcαR阳性多形核白细胞的致病激活与治疗性阻断

Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus.
PubMed 文献 · J Invest Dermatol · 2021-07-08

本研究针对IgA天疱疮建立体外疾病模型,采用皮肤冰冻切片实验与人皮肤器官培养模型,研究抗角质形成细胞IgA与细胞表面FcαR的相互作用。结果显示该病依赖FcαR介导的表皮内白细胞激活,肽介导的FcαR:IgA-Fc相互作用抑制可剂量依赖性阻断该病理过程,并在IgA血管炎模型中得到验证。

要点

  • IgA天疱疮的病理依赖FcαR介导的表皮内白细胞激活。
  • 抗桥粒芯糖蛋白3 IgA自身抗体可介导该病的致病过程。
  • 肽介导抑制FcαR:IgA-Fc相互作用可剂量依赖性阻断病理。

核心结论

  • IgA天疱疮可在体外建模,其病理依赖FcαR介导的白细胞激活。
  • IgA天疱疮与IgA血管炎均为FcαR依赖性疾病实体,可在实验系统中被特异性靶向。

研究设计与样本

  • 采用多种体外实验,包括皮肤冰冻切片实验和人皮肤器官培养模型。
  • 研究抗桥粒芯糖蛋白3 IgA自身抗体与细胞表面FcαR的相互作用。
  • 另在IgA血管炎模型中验证FcαR:IgA-Fc相互作用的抑制作用。

主要发现

  • IgA天疱疮的致病过程依赖FcαR介导的表皮内白细胞激活。
  • 肽介导抑制FcαR:IgA-Fc相互作用可剂量依赖性消除该细胞依赖性病理。
  • 上述抑制效果在IgA血管炎模型中亦得到确认。

临床怎么用

  • FcαR:IgA-Fc相互作用可作为IgA天疱疮实验系统中的特异性干预靶点。
  • 所建立的体外模型可用于研究IgA天疱疮的致病机制与干预效果。

局限性

  • 原文指出该病此前缺乏疾病模型和更详细的病理生理数据,本研究为体外模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pathomechanisms in IgA pemphigus are assumed to rely on Fc-dependent cellular activation by antigen-specific IgA autoantibodies; however, models for the disease and more detailed pathophysiologic data are lacking. In this study, we aimed to establish in vitro models of disease for IgA pemphigus, allowing us to study the effects of the interaction of anti-keratinocyte IgA with cell surface FcαRs. Employing multiple in vitro assays, such as a skin cryosection assay and a human skin organ culture model, in this study, we present mechanistic data for the pathogenesis of IgA pemphigus, mediated by anti-desmoglein 3 IgA autoantibodies. Our results reveal that this disease is dependent on FcαR-mediated activation of leukocytes in the epidermis. Importantly, this cell-dependent pathology can be dose-dependently abrogated by peptide-mediated inhibition of FcαR:IgA-Fc interaction, as confirmed in an additional model for IgA-dependent disease, that is, IgA vasculitis. These data suggest that IgA pemphigus can be modeled in vitro and that IgA pemphigus and IgA vasculitis are FcαR-dependent disease entities that can be specifically targeted in these experimental systems.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Emtenani S, Ghorbanalipoor S, Mayer-Hain S, et al. Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus. J Invest Dermatol. 2021. PMID: 34246620. doi:10.1016/j.jid.2021.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。